Fate Therapeutics, Inc. (FATE)
Market: NASD |
Currency: USD
Address: 12278 Scripps Summit Drive
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Show more
📈 Fate Therapeutics, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$5.40
-
Upside/Downside from Analyst Target:
346.28%
-
Broker Call:
7
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
100-200%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Fate Therapeutics, Inc.
| Date | Reported EPS |
|---|
| 2026-05-11 (estimated upcoming) | - |
| 2026-03-03 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-09 (estimated upcoming) | - |
| 2025-08-11 (estimated upcoming) | - |
| 2025-08-10 (estimated upcoming) | - |
| 2025-05-13 | - |
| 2025-05-08 | - |
| 2025-05-07 | - |
| 2025-05-06 | - |
| 2025-03-05 | -0.44 |
| 2024-11-12 | -0.4 |
| 2024-08-13 | -0.33 |
| 2024-08-12 | -0.33 |
| 2024-05-09 | -0.47 |
| 2024-05-08 | -0.47 |
| 2024-02-26 | -0.45 |
| 2024-02-25 | -0.45 |
| 2023-11-08 | -0.46 |
| 2023-11-07 | -0.46 |
| 2023-08-08 | -0.54 |
| 2023-08-07 | -0.54 |
| 2023-05-03 | -0.19 |
| 2023-05-02 | -0.19 |
| 2023-02-28 | -0.58 |
| 2023-02-27 | -0.58 |
| 2022-11-03 | -0.86 |
| 2022-11-02 | -0.86 |
| 2022-08-03 | -0.79 |
| 2022-08-02 | -0.79 |
| 2022-05-04 | -0.68 |
| 2022-05-03 | -0.68 |
| 2022-02-28 | -0.72 |
| 2022-02-27 | -0.72 |
| 2021-11-04 | -0.45 |
| 2021-11-03 | -0.45 |
| 2021-08-04 | -0.58 |
| 2021-08-03 | -0.58 |
| 2021-05-05 | -0.48 |
| 2021-05-04 | -0.48 |
| 2021-02-24 | -0.61 |
| 2021-02-23 | -0.61 |
| 2020-11-05 | -0.68 |
| 2020-11-04 | -0.68 |
| 2020-08-05 | -0.35 |
| 2020-08-04 | -0.35 |
| 2020-05-11 | -0.44 |
| 2020-05-10 | -0.44 |
| 2020-03-02 | -0.37 |
| 2020-03-01 | -0.37 |
| 2019-11-04 | -0.4 |
| 2019-08-05 | -0.36 |
| 2019-05-06 | -0.3 |
| 2019-03-04 | -0.25 |
| 2018-10-31 | -0.31 |
| 2018-08-05 | -0.37 |
| 2018-05-09 | -0.27 |
| 2018-03-04 | -0.29 |
| 2017-10-31 | -0.26 |
| 2017-08-13 | -0.23 |
| 2017-05-14 | -0.24 |
| 2017-03-15 | -0.21 |
| 2016-11-06 | -0.27 |
| 2016-08-07 | -0.29 |
| 2016-05-08 | -0.29 |
| 2016-03-02 | -0.26 |
| 2015-11-02 | -0.24 |
| 2015-08-04 | -0.33 |
| 2015-05-06 | -0.38 |
| 2015-03-11 | -0.3 |
| 2014-11-10 | -0.3 |
| 2014-08-11 | -0.3 |
| 2014-05-12 | -0.34 |
| 2014-03-16 | -0.29 |
| 2013-11-12 | -4.81 |
📰 Related News & Research
No related articles found for "fate therapeutics".
